Inlyta

Inlyta Indications/Uses

axitinib

Manufacturer:

Pfizer
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Axitinib is indicated for the treatment of patients with advanced renal cell carcinoma (RCC) of clear cell histology after failure of one prior systemic therapy with sunitinib, cytokine or sorafenib (see Pharmacology: Pharmacodynamics under Actions).
Axitinib should be prescribed by a qualified healthcare professional who is experienced in the use of anti-neoplastic therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in